National Planning Corporation’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-10,527
| Closed | -$357K | – | 83 |
|
|
2017
Q3 | $357K | Sell |
10,527
-4,074
| -28% | -$138K | 0.03% | 462 |
|
|
2017
Q2 | $495K | Sell |
14,601
-1,926
| -12% | -$65.3K | 0.04% | 410 |
|
|
2017
Q1 | $517K | Buy |
16,527
+605
| +4% | +$18.9K | 0.04% | 375 |
|
|
2016
Q4 | $439K | Sell |
15,922
-986
| -6% | -$27.2K | 0.03% | 405 |
|
|
2016
Q3 | $472K | Sell |
16,908
-834
| -5% | -$23.3K | 0.04% | 374 |
|
|
2016
Q2 | $607K | Buy |
17,742
+175
| +1% | +$5.99K | 0.05% | 337 |
|
|
2016
Q1 | $491K | Sell |
17,567
-952
| -5% | -$26.6K | 0.04% | 356 |
|
|
2015
Q4 | $556K | Buy |
18,519
+15
| +0.1% | +$450 | 0.05% | 377 |
|
|
2015
Q3 | $595K | Sell |
18,504
-56,810
| -75% | -$1.83M | 0.05% | 309 |
|
|
2015
Q2 | $1.28M | Buy |
75,314
+37,782
| +101% | +$643K | 0.12% | 180 |
|
|
2015
Q1 | $1.26M | Sell |
37,532
-1,318
| -3% | -$44.4K | 0.11% | 175 |
|
|
2014
Q4 | $1.32M | Sell |
38,850
-208
| -0.5% | -$7.08K | 0.09% | 198 |
|
|
2014
Q3 | $1.36M | Buy |
39,058
+1,904
| +5% | +$66.5K | 0.1% | 193 |
|
|
2014
Q2 | $1.38M | Buy |
37,154
+1,146
| +3% | +$42.6K | 0.11% | 191 |
|
|
2014
Q1 | $1.18M | Buy |
36,008
+3,318
| +10% | +$109K | 0.1% | 204 |
|
|
2013
Q4 | $968K | Buy |
32,690
+10,034
| +44% | +$297K | 0.09% | 232 |
|
|
2013
Q3 | $588K | Buy |
22,656
+8,316
| +58% | +$216K | 0.06% | 318 |
|
|
2013
Q2 | $340K | Buy |
+14,340
| New | +$340K | 0.04% | 358 |
|